Introduction
The Dog CD279/PDCD1/PD1 HEK293T Stable Cell Line is a unique and valuable tool for studying the role of the programmed cell death protein 1 (PD-1) pathway in canine immune responses. This cell line is derived from human embryonic kidney (HEK) 293T cells and stably expresses the canine PD-1 protein, also known as CD279 or PDCD1. In this article, we will discuss the structure, activity, and potential applications of this cell line in canine immunology research.
Structure of Dog CD279/PDCD1/PD1 HEK293T Stable Cell Line
The Dog CD279/PDCD1/PD1 HEK293T Stable Cell Line is a genetically modified cell line that expresses the canine PD-1 protein. This protein is a type I transmembrane receptor that belongs to the CD28/CTLA-4 family of immune checkpoint molecules. The canine PD-1 protein shares a high degree of sequence homology with its human counterpart, with 88% amino acid identity and 93% similarity. It consists of an extracellular IgV-like domain, a transmembrane domain, and an intracellular domain with an immunoreceptor tyrosine-based inhibitory motif (ITIM) and an immunoreceptor tyrosine-based switch motif (ITSM).
Activity of Dog CD279/PDCD1/PD1 HEK293T Stable Cell Line
The PD-1 pathway plays a critical role in regulating immune responses and maintaining immune homeostasis. Upon binding to its ligands, PD-L1 and PD-L2, the PD-1 receptor transmits inhibitory signals that dampen T cell activation and proliferation. This serves as a crucial mechanism for preventing excessive immune responses and avoiding autoimmunity. Dysregulation of the PD-1 pathway has been implicated in various diseases, including cancer, autoimmune disorders, and infectious diseases.
The Dog CD279/PDCD1/PD1 HEK293T Stable Cell Line provides a valuable tool for studying the activity of the canine PD-1 pathway. This cell line can be used to investigate the binding affinity and kinetics of canine PD-1 to its ligands, as well as the downstream signaling events that occur upon ligand binding. It can also be used to screen for potential inhibitors or modulators of the PD-1 pathway.
Application of Dog CD279/PDCD1/PD1 HEK293T Stable Cell Line
One of the most significant applications of the Dog CD279/PDCD1/PD1 HEK293T Stable Cell Line is in the field of cancer immunotherapy. The PD-1 pathway has emerged as a promising therapeutic target for cancer treatment, and several PD-1 inhibitors have been approved for use in humans. As dogs are susceptible to various types of cancer, this cell line can be used to study the efficacy and potential side effects of PD-1 inhibitors in canine cancer models. It can also be used to assess the potential of combining PD-1 inhibitors with other cancer treatments.
In addition to cancer research, the Dog CD279/PDCD1/PD1 HEK293T Stable Cell Line can also be used to investigate the role of the PD-1 pathway in other canine diseases, such as autoimmune disorders and infectious diseases. It can also serve as a valuable tool for exploring the evolutionary conservation and functional differences of the PD-1 pathway between humans and dogs.
Conclusion
The Dog CD279/PDCD1/PD1 HEK293T Stable Cell Line is a unique and versatile tool for studying the canine PD-1 pathway. Its stable expression of the canine PD-1 protein allows for the investigation of the structure, activity, and potential applications of this important immune checkpoint molecule.
There are no reviews yet.